{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T14:05:36Z","timestamp":1762005936974,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1593,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41379-018-0066-y","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T14:42:25Z","timestamp":1526913745000},"page":"1400-1403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Glypican-1 immunohistochemistry does not separate mesothelioma from pulmonary adenocarcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Kenrry","family":"Chiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Churg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-018-0066-y_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-018-0066-y_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-018-0066-y_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-018-0066-y_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/modpathol.3800534","article-title":"Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity","volume":"19","author":"Yaziji","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0066-y_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2009.06.014","article-title":"Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma","volume":"41","author":"Bishop","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-018-0066-y_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dc.21380","article-title":"Usefulness of claudin 4 in the cytological diagnosis of serosal effusions","volume":"39","author":"Lonardi","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/s41379-018-0066-y_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1309\/AJCP0B3YJBXWXJII","article-title":"Value of claudin-4 immunostaining in the diagnosis of mesothelioma","volume":"139","author":"Ordonez","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-018-0066-y_bib8","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1111\/j.1742-4658.2010.07800.x","article-title":"Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting","volume":"277","author":"Theocharis","year":"2010","journal-title":"FEBS J"},{"issue":"5","key":"10.1038\/s41379-018-0066-y_bib9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/modpathol.2017.190","article-title":"Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","volume":"31","author":"Amatya","year":"2018","journal-title":"Modern Pathology"},{"key":"10.1038\/s41379-018-0066-y_bib10","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.2353\/ajpath.2006.050800","article-title":"Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells","volume":"168","author":"Su","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-018-0066-y_bib11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/ijc.31124","article-title":"Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer","volume":"142","author":"Matsuzaki","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-018-0066-y_bib12","first-page":"5562","article-title":"Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells","volume":"61","author":"Matsuda","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-018-0066-y_bib13","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI4105","article-title":"The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer","volume":"102","author":"Kleeff","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1038\/s41379-018-0066-y_bib14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/cam4.1064","article-title":"Elevated glypican\u20101 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma","volume":"6","author":"Lu","year":"2017","journal-title":"Cancer Med"},{"key":"10.1038\/s41379-018-0066-y_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.wneu.2017.05.165","article-title":"High expression of glypican-1 predicts dissemination and poor prognosis in glioblastomas","volume":"105","author":"Saito","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1038\/s41379-018-0066-y_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/bjc.2016.183","article-title":"Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma","volume":"115","author":"Hara","year":"2016","journal-title":"Br J Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0066-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222011504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222011504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:44:52Z","timestamp":1760229892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222011504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0893395222011504"],"URL":"https:\/\/doi.org\/10.1038\/s41379-018-0066-y","relation":{},"ISSN":["0893-3952"],"issn-type":[{"type":"print","value":"0893-3952"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glypican-1 immunohistochemistry does not separate mesothelioma from pulmonary adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-018-0066-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}